Amplia Therapeutics secures FDA fast track status for narmafotinib in pancreatic cancer, stock surges

Pallavi Madhiraju- September 20, 2024 0

Amplia Therapeutics Limited (ASX: ATX) has announced that its Focal Adhesion Kinase (FAK) inhibitor, narmafotinib, has been granted Fast Track Designation by the United States ... Read More

Comprehensive overview of detecting and treating pancreatic cancer

pharmanewsdaily- June 21, 2024 0

Detecting pancreatic cancer effectively relies on several critical diagnostic tools. Key among them is the pancreatic biopsy, a definitive test for identifying cancerous cells. Imaging ... Read More

Understanding Pancreatic Cancer: Incidence, Symptoms, and Prevention

pharmanewsdaily- June 21, 2024 0

Pancreatic cancer, medically termed "Pancreatic Carcinoma," is a serious condition originating in the pancreas, an essential organ located behind the stomach. The pancreas plays a ... Read More

Exscientia begins enrollment for Phase 1/2 cancer trial of CDK7 inhibitor

Pallavi Madhiraju- July 11, 2023 0

AI-driven precision medicine company Exscientia has initiated enrollment for its Phase 1/2 "ELUCIDATE" study, marking the first trial of its precision-designed CDK7 inhibitor, GTAEXS617 ('617), ... Read More

Zai Lab treats first patient in China in PANOVA-3 trial of TTFields

pallavi123- January 15, 2022 0

Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase 3 clinical trial of tumor treating fields ... Read More

Lantern Pharma bags FDA orphan drug status for LP-184 in pancreatic cancer

pallavi123- August 11, 2021 0

Lantern Pharma has secured orphan drug designation for its small molecule drug candidate LP-184 from the US Food and Drug Administration (FDA) for the treatment ... Read More

Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419

pharmanewsdaily- July 14, 2020 0

Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer efficacy clinical trial of the combination of ... Read More

Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer

pharmanewsdaily- February 13, 2020 0

Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has secured $1 million in debt financing led by California-based venture ... Read More

Pancreatic Cancer – How to Avoid? Causes, Symptoms & Treatment

pharmanewsdaily- May 16, 2013 0

What is meant by Pancreatic Cancer? Pancreatic Cancer is known as “Pancreatic Carcinoma”. Pancreatic Cancer What are pancreas and what is its function? Pancreas is ... Read More